Through its Centers of Excellence program, the MDS Foundation helps patients get appointments with leading experts from around the world. For patients with cancer there is no time to waste. The MDS ...

WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound ...

Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to myeloMATCH, a unique portfolio of clinical trials to test precision medicine ...

Exactly a month after Gilead Sciences revealed it had shelved a myelodysplastic syndromes (MDS) program for magrolimab, the molecule has been placed under a partial clinical hold by the FDA for its ...

Long-term RELAZA2 data showed MRD-guided therapy may improve outcomes for AML and MDS patients through earlier intervention.